XNCR

Xencor Inc

27.14
0.04 (0.15%)

Xencor Inc. (XNCR) Fundamentals

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
SHARE INFORMATION
Market CapUS$ 1,639,006,122
Shares Outstanding60,390,793
Float58,960,000
Percent Float97.63%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 19,000,000
Latest Fiscal EPSUS$ -1.02
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions492
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months4,318,227
Institutional Holdings Percent88.5%
Institutional Sold Previous 3 Months4,307,841
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months108,794
Insider Holdings Percent1.1
Insider Sold Previous 3 Months31,108
Insider Shares Owned633,997
TRADING INFO
52 Week HighUS$ 38.20
52 Week LowUS$ 19.36
52 Week High ChangeUS$ 24.55
21 Day Moving AverageUS$ 27.1981
21 Day Extended Moving AverageUS$ 27.3241
50 Day Moving AverageUS$ 27.6702
50 Day Extended Moving AverageUS$ 27.908
200 Day Moving AverageUS$ 28.6822
200 Day Extended Moving AverageUS$ 28.9139
10 Day Average Volume272,473
20 Day Average Volume272,351
30 Day Average Volume269,484
50 Day Average Volume280,096
Alpha-0.006704
Beta0.7629
Standard Deviation0.117069
R20.122694
7 Day Price ChangeUS$ -0.03
7 Day Percent Change-0.11%
21 Day Price ChangeUS$ 0.44
21 Day Percent Change1.65%
30 Day Price ChangeUS$ 0.07
30 Day Percent Change0.26%
Month to Date Price ChangeUS$ 0.04
Month to Date Percent Change0.15%
Quarter to Date Price ChangeUS$ -0.75
Quarter to Date Percent Change-2.69%
180 Day Price ChangeUS$ -2.97
180 Day Percent Change-9.86%
200 Day Price ChangeUS$ -2.31
200 Day Percent Change-7.84%
Year to Date Price ChangeUS$ 1.10
Year to Date Percent Change4.22%

Xencor Inc. (XNCR) Key Ratios

PROFITABILITY
EBIT Margin-136.5%
EBITDA Margin-129.9%
Pre-Tax Profit Margin-13.5%
Profit Margin Count-3.2%
Gross Margin41.4%
Profit Margin TOT-3.2%
INCOME STATEMENTS
RevenueUS$ 19,000,000
Revenue Per ShareUS$ 0.3146
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.50
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio9.70
Leverage Ratio1.20
Quick Ratio9.30
Long Term Debt To Capital0.07
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 1,117,811,490
Price to Sales16.18
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book2.40
Price To Cash Flow-13.40
PE Low Last 5 Years0.00
Price to Tangible Book2.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.80
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-16.45
Return on Equity-18.56
Return on Capital-18.74

Xencor Inc. (XNCR) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOBassil I. Dahiyat
Employees254
Last Audit-
CIK0001326732
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address111 West Lemon Avenue
Monrovia, CA 91016
Websitehttp://www.xencor.com
Facsimile-
Telephone+1 626 305-5900
Emailinfo@xencor.com
Your Recent History
NASDAQ
XNCR
Xencor
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230602 01:48:22